Colon cancer treatment based on modeling of patient's cancer sample

Comparison of the effect of treatment outcome in patients with colon cancer based on personalized organoid modeling with the recommended standard method

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120216009045N6

Enrollment

Registered

2024-12-17

Start date

2024-12-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer. Malignant neoplasm of colon

Interventions

Intervention 1: Intervention group: In this group, the surgeon will prepare a cancerous tissue sample during surgery. Part of the sample in formalin will be sent to the hospital pathology department f

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with colon cancer who have a definitive diagnosis and are candidates for surgery for the first time

Exclusion criteria

Exclusion criteria: Colon tumor recurrence Metastatic cancer Concomitant cancer Adjuvant therapy recipients Inoperable patients

Design outcomes

Primary

Measure	Time frame
Determining the best medication with the best dosage for each patient. Timepoint: After intervention. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Taghi Beigmohamadi

Tehran University of Medical Sciences

mbage46@gmail.com+98 21 6119 2512

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026